scholarly journals Factors impacting the efficacy of venlafaxine extended release 75–225 mg/day in patients with major depressive disorder: exploratory post hoc subgroup analyses of a randomized, double-blind, placebo-controlled study in Japan

2018 ◽  
Vol Volume 14 ◽  
pp. 1261-1272 ◽  
Author(s):  
Yoshinori Watanabe ◽  
Yuko Asami ◽  
Yoko Hirano ◽  
Kazuhiko Kuribayashi ◽  
Rio Itamura ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Extended Release ◽  
Controlled Study ◽  
Major Depressive ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Subgroup Analyses ◽  
Post Hoc

scholarly journals Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features: A Randomized, Double-Blind, Placebo-Controlled Study

2016 ◽  
Vol 173 (4) ◽  
pp. 400-407 ◽  
Author(s):  
Trisha Suppes ◽  
Robert Silva ◽  
Josephine Cucchiaro ◽  
Yongcai Mao ◽  
Steven Targum ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Controlled Study ◽  
Major Depressive ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Mixed Features
Sign in / Sign up

Export Citation Format

Share Document